On September 8th, from 16:00 – 17:15, our keynote speaker will be Prof. Dr. Karine Clément of the Sorbonne Université in France. She will be joined by Inez Trouwborst of Maastricht University.
Prof. Dr. Karine Clément (Sorbonne Université)
“Adipose tissue fibrosis: from clinic to cellular mechanisms”
Karine Clément (MD, PhD) is medical doctor, full professor of Nutrition at Pitié-Salpêtrière hospital and Sorbonne University in Paris. Since 2002, her research unit at INSERM works on the pathophysiology of obesity and related disorders particularly focusing on interorgan cross-talks (www.nutriomique.org, @ClementLab).
From 2011-2016, she created and was the director of the Institute of CardiometAbolisme and Nutrition. KC has been first involved in genetics of obesity and contributed to the identification of monogenic forms of obesity, a field where new medical treatments are now available to patients. Her group is also exploring the link between environmental changes (as changes in lifestyle and nutrition), gut microbiota, immune system and tissue functional modifications (adipose tissue fibrosis and inflammation). KC and her group contributed to more than 450 highly cited publications. KC received several national and international prizes and contributes to several science advisory boards and international consortia. Amongst them FP7-METACARDIS is a EU project dedicated to the study of gut microbiota in Cardiometabolic diseases and KC was coordinator of Metacardis for 6 years. KC is a member of several international groups and association (such as WOF, EASO, EASD, AFERO as vice president) and received several national and international prizes (such Irene Jolliot-Curie, Gallien, Fondation de France (Valade) and Jacoebaus international prizes).
Inez Trouwborst (Maastricht University)
“Systemic and abdominal subcutaneous adipose tissue immune cells in tissue-specific insulin resistance in overweight and obesity”
Inez Trouwborst is a final year PhD candidate at the department of Human Biology at Maastricht University in The Netherlands. She has a background in Nutrition and Health and is interested in the relationship between nutrition, metabolism, and health in humans. Her research focusses on the effect of targeted, more personalized, nutrition to prevent and treat obesity-related metabolic diseases in an in vivo clinical setting. She is specifically looking into distinct metabolic phenotypes towards cardiometabolic diseases, focusing on insulin resistance, body composition, and local and systemic inflammation.